ArticleAdvanced healthcare materials2013
μHall chip for sensitive detection of bacteria.
Article in Advanced healthcare materials, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Integrated Microfluidic Giant Magnetoresistance (GMR) Biosensor Platform for Magnetoresistive Immunoassay of Myoglobin.Biosensors · 2025Article
- Roadmap on magnetic nanoparticles in nanomedicine.Nanotechnology · 2024Review
- Minimizing Contact Resistance and Flicker Noise in Micro Graphene Hall Sensors Using Persistent Carbene Modified Gold Electrodes.ACS applied materials & interfaces · 2024Article
- Microfluidics-Based Nanobiosensors for Healthcare Monitoring.Molecular biotechnology · 2024Review
- Highly stable integration of graphene Hall sensors on a microfluidic platform for magnetic sensing in whole blood.Microsystems & nanoengineering · 2023Article
- Evolution in Automatized Detection of Cells: Advances in Magnetic Microcytometers for Cancer Cells.Advances in experimental medicine and biology · 2022Review
- Nanotools for Sepsis Diagnosis and Treatment.Advanced healthcare materials · 2021Review
- Rapid bacterial detection and antibiotic susceptibility testing in whole blood using one-step, high throughput blood digital PCR.Lab on a chip · 2020Article
- Article
- Emerging Microtechnologies and Automated Systems for Rapid Bacterial Identification and Antibiotic Susceptibility Testing.SLAS technology · 2017Article
- Integrated microHall magnetometer to measure the magnetic properties of nanoparticles.Lab on a chip · 2017Article
- Click Chemistry-Mediated Nanosensors for Biochemical Assays.Theranostics · 2016Review
- Recent Developments in Magnetic Diagnostic Systems.Chemical reviews · 2015Review
- Point-of-care rare cell cancer diagnostics.Methods in molecular biology (Clifton, N.J.) · 2015Article
- Miniaturized, multiplexed readout of droplet-based microfluidic assays using time-domain modulation.Lab on a chip · 2014Article
- A multi-scale PDMS fabrication strategy to bridge the size mismatch between integrated circuits and microfluidics.Lab on a chip · 2014Article
- Track-etched magnetic micropores for immunomagnetic isolation of pathogens.Advanced healthcare materials · 2014Article
- Microchip-based detection of magnetically labeled cancer biomarkers.Advanced drug delivery reviews · 2014Review
- Laser micromachined hybrid open/paper microfluidic chips.Biomicrofluidics · 2013Article
- Supervised discriminant analysis for droplet micro-magnetofluidics.Microfluidics and nanofluidicsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Sensitive, rapid and phenotype-specific enumeration of pathogens is essential for the diagnosis of infectious disease, monitoring of food chains, and for defense against bioterrorism. Microbiological culture and genotyping, techniques that sensitively and selectively detect bacteria in laboratory settings, have limited application in clinical environments due to high cost, slow response times, and the need for specially trained staff and laboratory infrastructure. To address these challenges, we developed a microfluidic chip-based micro-Hall (μHall) platform capable of measuring single, magnetically tagged bacteria directly in clinical specimens with minimal sample processing. We demonstrated the clinical utility of the μHall chip by enumerating Gram-positive bacteria. The overall detection limit of the system was similar to that of culture tests (~10 bacteria), but the assay time was 50-times faster. This low-cost, single-cell analytical technique is especially well-suited to diagnose infectious diseases in resource-limited clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.